Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

DPACE regimen

A regimen consisting of dexamethasone, cisplatin, doxorubicin, cyclophosphamide and etoposide that may be used as a salvage regimen for aggressive and/or refractory plasma cell myeloma.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	cisplatin/cyclophosphamide/dexamethasone/doxorubicin/etoposide cisplatin/cyclophosphamide/dexamethasone/doxorubicin/etoposide regimen decadron/platinol/adriamycin/cytoxan/etoposide regimen dexamethasone-cisplatin-doxorubicin-cyclophosphamide-etoposide regimen dexamethasone/cisplatin/doxorubicin/cyclophosphamide/etoposide dexamethasone/cisplatin/doxorubicin/cyclophosphamide/etoposide regimen
Abbreviation:	D-PACE DPACE

DPACE regimen

Search NCI's Drug Dictionary